Death-associated protein kinase 1 is an IRF3/7-interacting protein that is involved in the cellular antiviral immune response

Cellular and Molecular Immunology

Volumn 11, Issue 3, 2014, Pages 245-252

  Zhang, Jing ^a   Hu, Ming Ming ^a   Shu, Hong Bing ^a   Li, Shu ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

DAPK1; innate antiviral response; IRF3 7; type I interferon

Indexed keywords

BETA INTERFERON; BETA1 INTERFERON; DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; RETINOIC ACID INDUCIBLE PROTEIN I; SERINE; UNCLASSIFIED DRUG; DAPK1 PROTEIN, HUMAN; IRF3 PROTEIN, HUMAN; IRF7 PROTEIN, HUMAN; PROTEIN BINDING;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; GENE; IFNB1 GENE; IMMUNOREGULATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; TANDEM AFFINITY PURIFICATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; DRUG EFFECTS; HUMAN; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION; VIRUS; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; IFNB 1 GENE; INTERFERON STIMULATED RESPONSE ELEMENT; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; RIG I GENE; VIRUS ACTIVATION;

DEATH-ASSOCIATED PROTEIN KINASES; HUMANS; IMMUNITY, CELLULAR; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON-BETA; PROTEIN BINDING; SIGNAL TRANSDUCTION; VIRUSES;

EID: 84899790584     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2013.65     Document Type: Article

References (41)

1. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820.
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
3. Garcia-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: A lesson in detente. Science 2006; 312: 879-882.
4. O'Neill, LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007; 7: 353-364.
5. Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 2003; 4: 161-167.
6. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301: 640-643.
7. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-Triggered IFN-beta signaling. Mol Cell 2005; 19: 727-740.
8. O'Neill LA, Bowie AG. Sensing and signaling in antiviral innate immunity. Curr Biol 2010; 20: R328-R333.
9. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491-496.
10. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300: 1148-1151.
11. Ermolaeva MA, Michallet MC, Papadopoulou N, Utermöhlen O, Kranidioti K, Kollias G et al. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008; 9: 1037-1046.
12. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J et al. TRADD protein is an essential component of the RIGlike helicase antiviral pathway. Immunity 2008; 28: 651-661.
13. Balachandran S, Venkataraman T, Fisher PB, Barber GN. Fasassociated death domain-containing protein-mediated antiviral innate immune signaling involves the regulation of Irf7. J Immunol 2007; 178: 2429-2439.
14. Zhong B, Yang Y, Li S, Wang YY, Li Y, Diao F et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 2008; 29: 538-550.
15. Lei CQ, Zhong B, Zhang Y, Zhang J, Wang S, Shu HB et al. Glycogen synthase kinase 3beta regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 2010; 33: 878-889.
16. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008; 26: 535-584.
17. Hiscott J. Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007; 282: 15325-15329.
18. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772-777.
19. Lu R, Au WC, Yeow WS, Hageman N, Pitha PM. Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon snd silencing by hypermethylation. J Biol Chem 2000; 275: 31805-31812.
20. Litvak V, Ratushny AV, Lampano AE, Schmitz F, Huang AC, Raman A et al. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 2012; 490: 421-425.
21. Wang RP, Zhang M, Li Y, Diao FC, Chen D, Zhai Z et al. Differential regulation of IKK alpha-mediated activation of IRF3/7 by NIK. Mol Immunol 2008; 45: 1926-1934.
22. Ning S, Campos AD, Darnay BG, Bentz GL, Pagano JS. TRAF6 and the three C-Terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol Cell Biol 2008; 28: 6536-6546.
23. Yu Y, Hayward GS. The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3. Immunity 2010; 33: 863-877.
24. Mao AP, Li S, Zhong B, Li Y, Yan J, Li Q et al. Virus-Triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-beta (IFN-beta) and cellular antiviral response. J Biol Chem 2010; 285: 9470-9476.
25. Li Y, Li C, Xue P, Zhong B, Mao AP, Ran Y et al. ISG56 is a negativefeedback regulator of virus-Triggered signaling and cellular antiviral response. Proc Natl Acad Sci USA 2009; 106: 7945-7950.
26. Diao F, Li S, Tian Y, Zhang M, Xu LG, Zhang Y et al. Negative regulation of MDA5-but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci USA 2007; 104: 11706-11711.
27. Huang J, Liu T, Xu LG, Chen D, Zhai Z, Shu HB. SIKE is an IKK epsilon/TBK1-Associated suppressor of TLR3-And virus-Triggered IRF-3 activation pathways. EMBO J 2005; 24: 4018-4028.
28. Chuang YT, Fang LW, Lin-Feng MH, Chen RH, Lai MZ. The tumor suppressor death-Associated protein kinase targets to TCR-stimulated NF-kappa B activation. J Immunol 2008; 180: 3238-3249.
29. Wang YY, Liu LJ, Zhong B, Liu TT, Li Y, Yang Y et al. WDR5 is essential for assembly of the VISA-Associated signaling complex and virus-Triggered IRF3 and NF-kappaB activation. Proc Natl Acad Sci USA 2010; 107: 815-820.
30. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 1995; 9: 15-30.
31. Levine B, Klionsky DJ. Development by self-digestion: Molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-477.
32. Bialik S, Kimchi, A. The death-Associated protein kinases: Structure, function, and beyond. Annu Rev Biochem 2006; 75: 189-210.
33. Kuo JC, Wang WJ, Yao CC, Wu PR, Chen RH. The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway. J Cell Biol 2006; 172: 619-631.
34. Harrison B, Kraus M, Burch L, Stevens C, Craig A, Gordon-Weeks P et al. DAPK-1 binding to a linear peptide motif in MAP1B stimulates autophagy and membrane blebbing. J Biol Chem 2008; 283: 9999-10014.
35. Kang BN, Ahmad AS, Saleem S, Patterson RL, Hester L, Doré S et al. Death-Associated protein kinase-mediated cell death modulated by interaction with DANGER. J Neurosci 2010; 30: 93-98.
36. Zidi I, Mestiri S, Bartegi A, Amor NB. TNF-Alpha and its inhibitors in cancer. Med Oncol 2009; 27: 185-198.
37. Perry AK, Chow EK, Goodnough JB, Yeh WC, Cheng G. Differential requirement for TANK-binding kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection. J Exp Med 2004; 199: 1651-1658.
38. Tenoever BR, Ng SL, Chua MA, McWhirter SM, García-Sastre A, Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 2007; 315: 1274-1278.
39. Shohat G, Spivak-Kroizman T, Cohen O, Bialik S, Shani G, Berrisi H et al. The pro-Apoptotic function of death-Associated protein kinase is controlled by a unique inhibitory autophosphorylation-based mechanism. J Biol Chem 2001; 276: 47460-47467.
40. Hsu H, Huang J, Shu HB, Baichwal V, Goeddel DV. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 1996; 4: 387-396.
41. Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245-257.